Novavax
NVAX
407 hedge funds and large institutions have $8.42B invested in Novavax in 2021 Q2 according to their latest regulatory filings, with 102 funds opening new positions, 135 increasing their positions, 108 reducing their positions, and 82 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 135 | Existing positions reduced: 108
24% more first-time investments, than exits
New positions opened: 102 | Existing positions closed: 82
9% more capital invested
Capital invested by funds: $7.69B → $8.42B (+$728M)
5% more funds holding
Funds holding: 389 → 407 (+18)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
3.92% less ownership
Funds ownership: 57.58% → 53.66% (-3.9%)
12% less call options, than puts
Call options by funds: $1.09B | Put options by funds: $1.23B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$142M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$59.9M |
| 3 |
Jane Street
New York
|
+$51.8M |
| 4 |
State Street
Boston,
Massachusetts
|
+$46.1M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$34.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$177M |
| 2 |
BlackRock
New York
|
-$168M |
| 3 |
Renaissance Technologies
New York
|
-$122M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$81M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$79.3M |
NVAX Hedge Fund Activity: Q2 2021 in Review
407 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q2 2021, worth a combined $8.42B — up 9.5% from $7.69B a quarter earlier.
Buyers outnumbered sellers: 102 funds opened new NVAX positions and 82 closed out — a net gain of 20 holders — while 135 added to existing stakes and 108 trimmed.
The largest buyer was Vanguard Group, adding an estimated $142M. The largest seller was Wellington Management Group, cutting an estimated $177M.
- 407 institutional investors held Novavax (NVAX) as of Q2 2021, up from 389 in Q1 2021.
- Funds reported $8.42B of Novavax stock for Q2 2021, up 9.5% quarter-over-quarter.
- 102 funds opened new Novavax positions in Q2 2021 and 82 closed out, a net change of +20 holders.
- The largest Novavax buyer in Q2 2021 was Vanguard Group, an estimated $142M added.
- The largest Novavax seller in Q2 2021 was Wellington Management Group, an estimated $177M sold.
Based on aggregated 13F filings for Q2 2021.